Dec 16 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES NEW PRELIMINARY DATA FOR ITS
IN-DEVELOPMENT
LUNG CANCER PORTFOLIO TESTS
    * VERACYTE INC - NONINVASIVE NASAL SWAB TEST AND ITS
PERCEPTA
GENOMIC ATLAS ARE IN DEVELOPMENT AND SCHEDULED TO LAUNCH IN
SECOND HALF OF 2021

Source text for Eikon:  urn:newsml:reuters.com:*:nBw7MgDtma
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))